High-affinity binding to staphylococcal protein A by an engineered dimeric Affibody molecule. 2013

Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
Affibody AB, Gunnar Asplunds Allé 24, SE-171 63 Solna, Sweden.

Affibody molecules are engineered binding proteins, in which the three-helix bundle motif of the Z domain derived from protein A is used as a scaffold for sequence variation. We used phage display to select Affibody binders to staphylococcal protein A itself. The best binder, called ZpA963, binds with similar affinity and kinetics to the five homologous E, D, A, B and C domains of protein A, and to a five-domain protein A construct with an average dissociation constant, K(D), of ~20 nM. The structure of ZpA963 in complex with the Z domain shows that it interacts with a surface on Z that is identical in the five protein A domains, which explains the multi-domain affinity. This property allows for high-affinity binding by dimeric Affibody molecules that simultaneously engage two protein A domains in a complex. We studied two ZpA963 dimers in which the subunits were linked by a C-terminal disulfide in a symmetric dimer or head-to-tail in a fusion protein, respectively. The dimers both bind protein A with high affinity, very slow off-rates and with saturation-dependent kinetics that can be understood in terms of dimer binding to multiple sites. The head-to-tail (ZpA963)2htt dimer binds with an off-rate of k(off) ≤ 5 × 10(-6) s(-1) and an estimated K(D) ≤ 16 pM. The results illustrate how dimers of selected monomer binding proteins can provide an efficient route for engineering of high-affinity binders to targets that contain multiple homologous domains or repeated structural units.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013205 Staphylococcal Protein A A protein present in the cell wall of most Staphylococcus aureus strains. The protein selectively binds to the Fc region of human normal and myeloma-derived IMMUNOGLOBULIN G. It elicits antibody activity and may cause hypersensitivity reactions due to histamine release; has also been used as cell surface antigen marker and in the clinical assessment of B lymphocyte function. Protein A,Protein A, Staphylococcal
D015202 Protein Engineering Procedures by which protein structure and function are changed or created in vitro by altering existing or synthesizing new structural genes that direct the synthesis of proteins with sought-after properties. Such procedures may include the design of MOLECULAR MODELS of proteins using COMPUTER GRAPHICS or other molecular modeling techniques; site-specific mutagenesis (MUTAGENESIS, SITE-SPECIFIC) of existing genes; and DIRECTED MOLECULAR EVOLUTION techniques to create new genes. Genetic Engineering of Proteins,Genetic Engineering, Protein,Proteins, Genetic Engineering,Engineering, Protein,Engineering, Protein Genetic,Protein Genetic Engineering
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D055503 Protein Multimerization The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS. Protein Dimerization,Protein Heteromultimerizaton,Protein Multimer Assembly,Protein Trimerization,Assembly, Protein Multimer,Dimerization, Protein,Heteromultimerizaton, Protein,Heteromultimerizatons, Protein,Multimer Assembly, Protein,Multimerization, Protein,Trimerization, Protein
D019151 Peptide Library A collection of cloned peptides, or chemically synthesized peptides, frequently consisting of all possible combinations of amino acids making up an n-amino acid peptide. Phage Display Peptide Library,Random Peptide Library,Peptide Phage Display Library,Phage Display Library, Peptide,Synthetic Peptide Combinatorial Library,Synthetic Peptide Library,Libraries, Peptide,Libraries, Random Peptide,Libraries, Synthetic Peptide,Library, Peptide,Library, Random Peptide,Library, Synthetic Peptide,Peptide Libraries,Peptide Libraries, Random,Peptide Libraries, Synthetic,Peptide Library, Random,Peptide Library, Synthetic,Random Peptide Libraries,Synthetic Peptide Libraries

Related Publications

Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
March 2010, Biotechnology and applied biochemistry,
Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
April 2006, Cancer research,
Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
December 2014, Proceedings of the National Academy of Sciences of the United States of America,
Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
August 2010, Proceedings of the National Academy of Sciences of the United States of America,
Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
March 2011, Protein expression and purification,
Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
January 2014, Toxins,
Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
May 2015, Analytical biochemistry,
Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
May 2013, Molecular pharmaceutics,
Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
March 2008, Journal of molecular biology,
Malin Lindborg, and Anatoly Dubnovitsky, and Kenneth Olesen, and Tomas Björkman, and Lars Abrahmsén, and Joachim Feldwisch, and Torleif Härd
March 2017, Experimental & molecular medicine,
Copied contents to your clipboard!